When will a Striverdi Respimat generic be available?
I can’t answer this from the information provided. “Striverdi Respimat” (olodaterol) generic availability depends on the specific drug’s remaining patent and regulatory exclusivity status in your country, plus whether an FDA/EMA approval has already been filed and granted.
What exactly should you check to know the likely generic timing?
Generic timing usually comes down to:
- Patent expiry dates for the active ingredient and key formulation/delivery device claims
- Regulatory exclusivity periods (in the US: e.g., 505(b)(2)/505(j) pathway timing doesn’t start until eligibility is met; in the EU: marketing authorisation and exclusivity rules apply)
- Whether generic manufacturers have an approved product already (or only a pending application)
Does “when” differ between the US and other countries?
Yes. A product can have patent/exclusivity dates that expire in one market earlier than another. Approval also depends on the relevant regulator (FDA in the US, EMA/national authorities in the EU, and so on).
If you tell me your country, I can narrow the answer
Reply with:
1) Your country (US, Canada, UK, EU country, etc.)
2) The strength/dose you mean (if you know it)
Then I can give a more specific “generic when” window based on the applicable regulatory/patent landscape.
Sources
No sources were provided in your prompt, so I didn’t cite any.